View all cases
UPC CFI 2220/2025
Dec 23, 2025·EP3666797 · ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
- Case details
- StatusWritten PhaseActionGenericCategoryGeneric
- Parties
- Respondents
- Sanofi-Aventis Deutschland GmbHOperating co.
- Sanofi-Aventis Groupe S.A.Operating co.
- Sanofi Winthrop IndustrieOperating co.
Representatives- Daniel Wise-Carpmaels & Ransford
- Division
- Munich CD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- EPO Opposition
- Sanofi-Aventis Deutschland GmbHAdmissible2023-11-10
- REGENERON PHARMACEUTICALS, INC.Admissible2024-02-19
- Sanofi-Aventis Groupe S.A.Withdrawn2023-11-10
- Sanofi Winthrop Industrie S.A.Withdrawn2023-11-10
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich CD | Locked |
| Judge András Kupecz | Locked |
| Judge Casper Struve | Locked |
At the UPC: Amgen Group (19 cases)·Sanofi Group (33 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 3 other proceedings
3 other defendants litigating the same or a related patent
Documents
Show all 13 documents| Document title | Date | Public |
|---|---|---|
| Receipt | 2026-01-26 | Not public |
| Cover sheet | 2026-01-26 | Not public |
| Document | 2026-01-26 | Not public |
| Receipt | 2026-01-16 | Not public |
| Cover sheet | 2026-01-16 | Not public |
| Receipt | 2026-01-16 | Not public |
| Cover sheet | 2026-01-16 | Not public |
| Application document Defendant | 2026-01-16 | Not public |
| Publication | 2026-01-07 | Not public |
| Other Documents | 2025-12-23 | Not public |